Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Reexamination Certificate
2007-11-06
2007-11-06
Swope, Sheridan L. (Department: 1652)
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
C435S320100, C435S252300, C435S252330, C435S325000, C435S254100, C435S070100, C435S071100
Reexamination Certificate
active
10838854
ABSTRACT:
The invention provides polynucleotides and polypeptides encoding an isolated amyloid inhibitor protein (APIP) and compositions thereof. The polypeptides of the subject invention can be used to inhibit the catabolism or sequential cleavage of amyloid beta precursor protein (APP) by sequential cleavage of APP by beta secretase and gamma secretase.
REFERENCES:
patent: 5744346 (1998-04-01), Chrysler et al.
patent: 5942400 (1999-08-01), Anderson et al.
patent: 6184241 (2001-02-01), Baures
patent: 6221645 (2001-04-01), Chrysler et al.
patent: 2006/0009633 (2006-01-01), Dumas Milne Edwards et al.
patent: 0 855 444 (1998-07-01), None
patent: WO99/31236 (1999-06-01), None
patent: WO 00/17369 (2000-03-01), None
patent: WO 00/47618 (2000-08-01), None
patent: WO 00/58479 (2000-10-01), None
patent: WO 01/00663 (2001-01-01), None
patent: WO 01/00665 (2001-01-01), None
Galye et al, Identification of regions in interleukin-1 alpha important for activity. J Biol Chem. Oct. 15, 1993;268(29):22105-11.
Whisstock et al, Prediction of protein function from protein sequence and structure. Q Rev Biophys. Aug. 2003;36(3):307-40. Review.
Published—Applications—NA—Main database SEQ ID No. 125 from US20060009633, priority to U.S. Appl. No. 09/215,435, filed Dec. 17, 1998 Edwards et al. Alignment with SEQ ID No. 23.
Pending—Patents—NA—Main database SEQ ID No. 66 from U.S. Appl. No. 09/215,435, filed Dec. 17, 1998 Edwards et al. Alignment with SEQ ID No. 23.
Sinha et al, Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. Dec. 2, 1999;402(6761):537-40.
NCBI Accession No. AAF18982 from Sinha et al, Nature. Dec. 2, 1999;402(6761):537-40. Alignment with SEQ ID No. 24.
Hong et al, Flap position of free memapsin 2 (beta-secretase), a model for flap opening in aspartic protease catalysis. Biochemistry. Apr. 27, 2004;43(16):4689-95.
Capell, A. et al. “Maturation and Pro-peptide Cleavage of B-Secretase”, The Journal of Biological Chemistry, Oct. 6, 2000, pp. 30849-30954, vol. 275, No. 40.
Shi, X. et al. “The Pro Domain of B-Secretase Does Not Confer Strict Zymogen-like Properties but Does Assist Proper Folding of the Protease Domain”, The Journal of Biological Chemistry, Mar. 30, 2001, pp. 10366-10373, vol. 276, No. 13.
Marcinkeviciene et al. “Mechanism of Inhibition of Beta-Site APP Cleaving Enzyme (BACE) By a Statine-Based Peptide”, JBC Paper in Press, Apr. 16, 2001.
Nixon, Ralph, “A Protease Activation Cascade′ in the Pathogenesis of Alzheimer's Disease”, Annals New York Academy of Sciences, 2000, pp. 117-131, Center for Dementia Research, Nathan Kline Institute, New York, US.
Benjannet, S. et al. “Post-translation Processing of B-Secretase (B-Amyloid-converting Enzyme) and its Ectodomain Shedding”, The Journal of Biological Chemistry, Apr. 6, 2001, pp. 10879-10887, vol. 276, No. 14.
Hussain, I. et al. “Prodomain Processing of ASP1 (BACE2) Is Autocatalytic”, JBC Papers in Press, Apr. 20, 2001 as Manscript M101069200.
Haniu, M. et al. “Characterization of Alzheimer's B-Secretase Protein BACE-A Pepsin Family Member with Unusual Properties”, The Journal of Biological Chemistry, Jul. 14, 2000, pp. 21099-21106, vol. 275, No. 28.
Walter, J. et al. “Phosphorylation Regulates Intracellular Trafficking of B-Secretase”, The Journal of Biological Chemistry, May 4, 2001, pp. 14634-14641, vol. 276, No. 18.
Bodendorf, U. et al. “A Splice Variant of B-Secretase Deficient in the Amyloidogenic Processing of the Amyloid Precursor Protein”, The Journal of Biological Chemistry, Apr. 13, 2001, pp. 12019-12023, vol. 276, No. 15.
Nunan, J. et al. “Regulation of APP Cleavage by a-, B- and y-secretases”, FEBS Letters, 2000, pp. 6-10, vol. 483, 0014-5793/00.
Vassar, R. et al. “Homo sapiensBeta-Site APP-Cleaving Enzyme (BACE), mRNA”, Science, 1999, pp. 735-741, vol. 286, No. 5440, Accession No. NM—012104.
Sinha, S. et al. “Homo sapiensBeta-Secretase mRNA, Complete Cds”, Nature, 1999, pp. 534-540, vol. 402, No. 671, Accession No. AF201468.
Vassar, R. et al. “Beta-Secretase Cleavage of Alzheimer's Amyloid Prescursor Protein by the Transmembrane Aspartic Protease BACE”, Science, 1999, pp. 735-741, vol. 286, Accession No. P56817.
Vassar, R. et al. “Beta-Secretase Cleavage of Alzheimer's Amyloid Prescursor Protein by the Transmembrane Aspartic Protease BACE”, Science, 1999, pp. 735-741, vol. 286, N. 5440, Accession No. AF190725.
Sinha et al. “Purification and Cloning of Amyloid Percursor Protein Beta-secretase from Human Brain”, Nature, Dec. 2, 1999, pp. 537-540, vol. 402, No. 6761.
Genbank Accession No. XM—006430, “Homo sapiensBeta-site APP-cleavage Enzyme (BACE), mRNA”, NCBI Annotation Project, Apr. 17, 2001, National Center for Biotechnology Information.
Genbank Accession No. AF338816, Michel, B. et al. “Homo sapiensBeta-site APP cleaving Enzyme Type B mRNA, Complete Cds”, Jan. 19, 2001, Max Planck Institute of Molecular Cell Biology and Genetics.
Genbank Accession No. AB050438, Tanahashi, H. “Homo sapiensBACE mRNA for Beta-site APP Cleaving Enzyme I-432, Complete Cds”, National Institute of Neuroscience, Division of Demyelinating Disease and Aging, Oct. 21, 2000.
Genbank Accession No. AF338817, Zacchetti, D. et al. “Homo sapiensBeta-site APP Cleaving Enzyme Type C mRNA, Complete Cds”, San Raffaele Scientific Institute, Jan. 19, 2001.
Genbank Accession No. AB050437, Tanahashi, H. “Homo sapiensBACE mRNA for Beta-Site APP Cleaving Enzyme I-457, Complete Cds”, National Institute of Neuroscience, Division of Demyelinating Disease and Aging, Oct. 21, 2000.
Genbank Accession No. AB050436, Tanahashi, H. “Homo sapiensBACE mRNA for Beta-Site APP Cleaving Enzyme I-476, Complete Cds”, National Institute of Neuroscience, Division of Demyelinating Disease and Aging, Oct. 21, 2000.
Bejanin Stéphane
Tanaka Hiroaki
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
Swope Sheridan L.
LandOfFree
β-Secretase variant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β-Secretase variant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β-Secretase variant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3888850